Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 3819 entries
Sorted by: Best Match Show Resources per page
Liposomal Formulations in Clinical Use: An Updated Review.

Pharmaceutics

Bulbake U, Doppalapudi S, Kommineni N, Khan W.
PMID: 28346375
Pharmaceutics. 2017 Mar 27;9(2). doi: 10.3390/pharmaceutics9020012.

Liposomes are the first nano drug delivery systems that have been successfully translated into real-time clinical applications. These closed bilayer phospholipid vesicles have witnessed many technical advances in recent years since their first development in 1965. Delivery of therapeutics...

Cite
Bulbake U, Doppalapudi S, Kommineni N, et al. Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics. 2017;9(2)doi: 10.3390/pharmaceutics9020012.
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017). Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics, 9(2), . https://doi.org/10.3390/pharmaceutics9020012
Bulbake, Upendra, et al. "Liposomal Formulations in Clinical Use: An Updated Review." Pharmaceutics vol. 9,2 (2017). doi: https://doi.org/10.3390/pharmaceutics9020012
Bulbake U, Doppalapudi S, Kommineni N, Khan W. Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics. 2017 Mar 27;9(2). doi: 10.3390/pharmaceutics9020012. PMID: 28346375; PMCID: PMC5489929.
Copy Download .nbib Format: NLM
Development of tea tree oil-loaded liposomal formulation using response surface methodology.

Journal of liposome research

Ge Y, Ge M.
PMID: 25799232
J Liposome Res. 2015 Sep;25(3):222-231. doi: 10.3109/08982104.2014.987786. Epub 2015 Mar 23.

The aim of this study is to prepare tea tree oil liposome (TTOL) and optimize the preparation condition by single factor experiment and statistical design. TTOL was prepared using a thin-film hydration with the combination of sonication method and...

Cite
Ge Y, Ge M. Development of tea tree oil-loaded liposomal formulation using response surface methodology. J Liposome Res. 2015;25(3):222-231doi: 10.3109/08982104.2014.987786.
Ge, Y., & Ge, M. (2015). Development of tea tree oil-loaded liposomal formulation using response surface methodology. Journal of liposome research, 25(3), 222-231. https://doi.org/10.3109/08982104.2014.987786
Ge, Yan, and Ge, Mingqiao. "Development of tea tree oil-loaded liposomal formulation using response surface methodology." Journal of liposome research vol. 25,3 (2015): 222-231. doi: https://doi.org/10.3109/08982104.2014.987786
Ge Y, Ge M. Development of tea tree oil-loaded liposomal formulation using response surface methodology. J Liposome Res. 2015 Sep;25(3):222-231. doi: 10.3109/08982104.2014.987786. Epub 2015 Mar 23. PMID: 25799232.
Copy Download .nbib Format: NLM
Liposomal delivery of a phosphodiesterase 3 inhibitor rescues low oxygen-induced ATP release from erythrocytes of humans with type 2 diabetes.

Biochemistry and biophysics reports

Dergunov SA, Bowles EA, Gordon W, Green M, Bierman A, Ellsworth ML, Pinkhassik E, Sprague RS.
PMID: 29124155
Biochem Biophys Rep. 2015 May 30;2:137-142. doi: 10.1016/j.bbrep.2015.05.011. eCollection 2015 Jul.

ATP release from erythrocytes in response to low oxygen tension requires an increase in cAMP, the level of which is regulated by phosphodiesterase 3 (PDE3). Such release is defective in erythrocytes of humans with type 2 diabetes (DM2). This...

Cite
Dergunov SA, Bowles EA, Gordon W, et al. Liposomal delivery of a phosphodiesterase 3 inhibitor rescues low oxygen-induced ATP release from erythrocytes of humans with type 2 diabetes. Biochem Biophys Rep. 2015;2:137-142doi: 10.1016/j.bbrep.2015.05.011.
Dergunov, S. A., Bowles, E. A., Gordon, W., Green, M., Bierman, A., Ellsworth, M. L., Pinkhassik, E., & Sprague, R. S. (2015). Liposomal delivery of a phosphodiesterase 3 inhibitor rescues low oxygen-induced ATP release from erythrocytes of humans with type 2 diabetes. Biochemistry and biophysics reports, 2137-142. https://doi.org/10.1016/j.bbrep.2015.05.011
Dergunov, Sergey A, et al. "Liposomal delivery of a phosphodiesterase 3 inhibitor rescues low oxygen-induced ATP release from erythrocytes of humans with type 2 diabetes." Biochemistry and biophysics reports vol. 2 (2015): 137-142. doi: https://doi.org/10.1016/j.bbrep.2015.05.011
Dergunov SA, Bowles EA, Gordon W, Green M, Bierman A, Ellsworth ML, Pinkhassik E, Sprague RS. Liposomal delivery of a phosphodiesterase 3 inhibitor rescues low oxygen-induced ATP release from erythrocytes of humans with type 2 diabetes. Biochem Biophys Rep. 2015 May 30;2:137-142. doi: 10.1016/j.bbrep.2015.05.011. eCollection 2015 Jul. PMID: 29124155; PMCID: PMC5668668.
Copy Download .nbib Format: NLM
Amadori-glycated phosphatidylethanolamine enhances the physical stability and selective targeting ability of liposomes.

Royal Society open science

Miyazawa T, Kamiyoshihara R, Shimizu N, Harigae T, Otoki Y, Ito J, Kato S, Miyazawa T, Nakagawa K.
PMID: 29515844
R Soc Open Sci. 2018 Feb 14;5(2):171249. doi: 10.1098/rsos.171249. eCollection 2018 Feb.

Liposomes consisting of 100% phosphatidylcholine exhibit poor membrane fusion, cellular uptake and selective targeting capacities. To overcome these limitations, we used Amadori-glycated phosphatidylethanolamine, which is universally present in animals and commonly consumed in foods. We found that liposomes containing...

Cite
Miyazawa T, Kamiyoshihara R, Shimizu N, et al. Amadori-glycated phosphatidylethanolamine enhances the physical stability and selective targeting ability of liposomes. R Soc Open Sci. 2018;5(2):171249doi: 10.1098/rsos.171249.
Miyazawa, T., Kamiyoshihara, R., Shimizu, N., Harigae, T., Otoki, Y., Ito, J., Kato, S., Miyazawa, T., & Nakagawa, K. (2018). Amadori-glycated phosphatidylethanolamine enhances the physical stability and selective targeting ability of liposomes. Royal Society open science, 5(2), 171249. https://doi.org/10.1098/rsos.171249
Miyazawa, Taiki, et al. "Amadori-glycated phosphatidylethanolamine enhances the physical stability and selective targeting ability of liposomes." Royal Society open science vol. 5,2 (2018): 171249. doi: https://doi.org/10.1098/rsos.171249
Miyazawa T, Kamiyoshihara R, Shimizu N, Harigae T, Otoki Y, Ito J, Kato S, Miyazawa T, Nakagawa K. Amadori-glycated phosphatidylethanolamine enhances the physical stability and selective targeting ability of liposomes. R Soc Open Sci. 2018 Feb 14;5(2):171249. doi: 10.1098/rsos.171249. eCollection 2018 Feb. PMID: 29515844; PMCID: PMC5830733.
Copy Download .nbib Format: NLM
A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines.

Cell journal

Haghiralsadat F, Amoabediny G, Sheikhha MH, Forouzanfar T, Helder MN, Zandieh-Doulabi B.
PMID: 28580308
Cell J. 2017;19:55-65. doi: 10.22074/cellj.2017.4502. Epub 2017 May 17.

OBJECTIVE: In this study we prepared a novel formulation of liposomal doxorubicin (L- DOX). The drug dose was optimized by analyses of cellular uptake and cell viability of osteosarcoma (OS) cell lines upon exposure to nanoliposomes that contained varying...

Cite
Haghiralsadat F, Amoabediny G, Sheikhha MH, et al. A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines. Cell J. 2017;19:55-65doi: 10.22074/cellj.2017.4502.
Haghiralsadat, F., Amoabediny, G., Sheikhha, M. H., Forouzanfar, T., Helder, M. N., & Zandieh-Doulabi, B. (2017). A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines. Cell journal, 1955-65. https://doi.org/10.22074/cellj.2017.4502
Haghiralsadat, Fateme, et al. "A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines." Cell journal vol. 19 (2017): 55-65. doi: https://doi.org/10.22074/cellj.2017.4502
Haghiralsadat F, Amoabediny G, Sheikhha MH, Forouzanfar T, Helder MN, Zandieh-Doulabi B. A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines. Cell J. 2017;19:55-65. doi: 10.22074/cellj.2017.4502. Epub 2017 May 17. PMID: 28580308; PMCID: PMC5448319.
Copy Download .nbib Format: NLM
Ultrasound-triggered local anaesthesia.

Nature biomedical engineering

Rwei AY, Paris JL, Wang B, Wang W, Axon CD, Vallet-Regí M, Langer R, Kohane DS.
PMID: 29152410
Nat Biomed Eng. 2017;1:644-653. doi: 10.1038/s41551-017-0117-6. Epub 2017 Aug 09.

On-demand relief of local pain would allow patients to control the timing, intensity and duration of nerve block in a safe and non-invasive manner. Ultrasound would be a suitable trigger for such a system, as it is in common...

Cite
Rwei AY, Paris JL, Wang B, et al. Ultrasound-triggered local anaesthesia. Nat Biomed Eng. 2017;1:644-653doi: 10.1038/s41551-017-0117-6.
Rwei, A. Y., Paris, J. L., Wang, B., Wang, W., Axon, C. D., Vallet-Regí, M., Langer, R., & Kohane, D. S. (2017). Ultrasound-triggered local anaesthesia. Nature biomedical engineering, 1644-653. https://doi.org/10.1038/s41551-017-0117-6
Rwei, Alina Y, et al. "Ultrasound-triggered local anaesthesia." Nature biomedical engineering vol. 1 (2017): 644-653. doi: https://doi.org/10.1038/s41551-017-0117-6
Rwei AY, Paris JL, Wang B, Wang W, Axon CD, Vallet-Regí M, Langer R, Kohane DS. Ultrasound-triggered local anaesthesia. Nat Biomed Eng. 2017;1:644-653. doi: 10.1038/s41551-017-0117-6. Epub 2017 Aug 09. PMID: 29152410; PMCID: PMC5687284.
Copy Download .nbib Format: NLM
Binding Protein-Dependent Uptake of Maltose into Cells via an ATP-Binding Cassette Transporter.

EcoSal Plus

Davidson AL, Alvarez FJ.
PMID: 26443785
EcoSal Plus. 2010 Sep;4(1). doi: 10.1128/ecosalplus.3.3.3.

Maltose and maltodextrins are actively transported across the cytoplasmic membrane of Escherichia coli and Salmonella by a periplasmic binding protein (BP)- dependent transport system. Since 1996, there have been many advances in the understanding of the structure and mechanism...

Cite
Davidson AL, Alvarez FJ. Binding Protein-Dependent Uptake of Maltose into Cells via an ATP-Binding Cassette Transporter. EcoSal Plus. 2010;4(1)doi: 10.1128/ecosalplus.3.3.3.
Davidson, A. L., & Alvarez, F. J. (2010). Binding Protein-Dependent Uptake of Maltose into Cells via an ATP-Binding Cassette Transporter. EcoSal Plus, 4(1), . https://doi.org/10.1128/ecosalplus.3.3.3
Davidson, Amy L, and Alvarez, Frances Joan D. "Binding Protein-Dependent Uptake of Maltose into Cells via an ATP-Binding Cassette Transporter." EcoSal Plus vol. 4,1 (2010). doi: https://doi.org/10.1128/ecosalplus.3.3.3
Davidson AL, Alvarez FJ. Binding Protein-Dependent Uptake of Maltose into Cells via an ATP-Binding Cassette Transporter. EcoSal Plus. 2010 Sep;4(1). doi: 10.1128/ecosalplus.3.3.3. PMID: 26443785; PMCID: PMC4255704.
Copy Download .nbib Format: NLM
Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer.

International journal of clinical and experimental medicine

Cao Y, Zhou Y, Zhuang Q, Cui L, Xu X, Xu R, He X.
PMID: 26550128
Int J Clin Exp Med. 2015 Aug 15;8(8):12182-91. eCollection 2015.

In this study, we report an active targeting liposomal formulation directed by a novel peptide (RGD) that specifically binds to the integrins receptors overexpressed on prostatic cancer cells. The objectives of this study were to evaluate the in vitro...

Cite
Cao Y, Zhou Y, Zhuang Q, et al. Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer. Int J Clin Exp Med. 2015;8(8):12182-91
Cao, Y., Zhou, Y., Zhuang, Q., Cui, L., Xu, X., Xu, R., & He, X. (2015). Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer. International journal of clinical and experimental medicine, 8(8), 12182-91.
Cao, Yunjie, et al. "Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer." International journal of clinical and experimental medicine vol. 8,8 (2015): 12182-91.
Cao Y, Zhou Y, Zhuang Q, Cui L, Xu X, Xu R, He X. Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer. Int J Clin Exp Med. 2015 Aug 15;8(8):12182-91. eCollection 2015. PMID: 26550128; PMCID: PMC4612813.
Copy Download .nbib Format: NLM
Lipid-based nano-delivery systems for skin delivery of drugs and bioactives.

Frontiers in pharmacology

Hua S.
PMID: 26483690
Front Pharmacol. 2015 Sep 30;6:219. doi: 10.3389/fphar.2015.00219. eCollection 2015.

No abstract available.

Cite
Hua S. Lipid-based nano-delivery systems for skin delivery of drugs and bioactives. Front Pharmacol. 2015;6:219doi: 10.3389/fphar.2015.00219.
Hua, S. (2015). Lipid-based nano-delivery systems for skin delivery of drugs and bioactives. Frontiers in pharmacology, 6219. https://doi.org/10.3389/fphar.2015.00219
Hua, Susan. "Lipid-based nano-delivery systems for skin delivery of drugs and bioactives." Frontiers in pharmacology vol. 6 (2015): 219. doi: https://doi.org/10.3389/fphar.2015.00219
Hua S. Lipid-based nano-delivery systems for skin delivery of drugs and bioactives. Front Pharmacol. 2015 Sep 30;6:219. doi: 10.3389/fphar.2015.00219. eCollection 2015. PMID: 26483690; PMCID: PMC4588690.
Copy Download .nbib Format: NLM
Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes.

ACS central science

Yang J, Bahreman A, Daudey G, Bussmann J, Olsthoorn RC, Kros A.
PMID: 27725960
ACS Cent Sci. 2016 Sep 28;2(9):621-630. doi: 10.1021/acscentsci.6b00172. Epub 2016 Aug 22.

Efficient delivery of drugs to living cells is still a major challenge. Currently, most methods rely on the endocytotic pathway resulting in low delivery efficiency due to limited endosomal escape and/or degradation in lysosomes. Here, we report a new...

Cite
Yang J, Bahreman A, Daudey G, et al. Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes. ACS Cent Sci. 2016;2(9):621-630doi: 10.1021/acscentsci.6b00172.
Yang, J., Bahreman, A., Daudey, G., Bussmann, J., Olsthoorn, R. C., & Kros, A. (2016). Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes. ACS central science, 2(9), 621-630. https://doi.org/10.1021/acscentsci.6b00172
Yang, Jian, et al. "Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes." ACS central science vol. 2,9 (2016): 621-630. doi: https://doi.org/10.1021/acscentsci.6b00172
Yang J, Bahreman A, Daudey G, Bussmann J, Olsthoorn RC, Kros A. Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes. ACS Cent Sci. 2016 Sep 28;2(9):621-630. doi: 10.1021/acscentsci.6b00172. Epub 2016 Aug 22. PMID: 27725960; PMCID: PMC5043431.
Copy Download .nbib Format: NLM
pH-Responsive Micelle-Based Cytoplasmic Delivery System for Induction of Cellular Immunity.

Vaccines

Yuba E, Sakaguchi N, Kanda Y, Miyazaki M, Koiwai K.
PMID: 29113042
Vaccines (Basel). 2017 Nov 04;5(4). doi: 10.3390/vaccines5040041.

(1) Background: Cytoplasmic delivery of antigens is crucial for the induction of cellular immunity, which is an important immune response for the treatment of cancer and infectious diseases. To date, fusogenic protein-incorporated liposomes and pH-responsive polymer-modified liposomes have been...

Cite
Yuba E, Sakaguchi N, Kanda Y, et al. pH-Responsive Micelle-Based Cytoplasmic Delivery System for Induction of Cellular Immunity. Vaccines (Basel). 2017;5(4)doi: 10.3390/vaccines5040041.
Yuba, E., Sakaguchi, N., Kanda, Y., Miyazaki, M., & Koiwai, K. (2017). pH-Responsive Micelle-Based Cytoplasmic Delivery System for Induction of Cellular Immunity. Vaccines, 5(4), . https://doi.org/10.3390/vaccines5040041
Yuba, Eiji, et al. "pH-Responsive Micelle-Based Cytoplasmic Delivery System for Induction of Cellular Immunity." Vaccines vol. 5,4 (2017). doi: https://doi.org/10.3390/vaccines5040041
Yuba E, Sakaguchi N, Kanda Y, Miyazaki M, Koiwai K. pH-Responsive Micelle-Based Cytoplasmic Delivery System for Induction of Cellular Immunity. Vaccines (Basel). 2017 Nov 04;5(4). doi: 10.3390/vaccines5040041. PMID: 29113042; PMCID: PMC5748608.
Copy Download .nbib Format: NLM
Translational nanoparticle engineering for cancer vaccines.

Oncoimmunology

Grippin AJ, Sayour EJ, Mitchell DA.
PMID: 29123947
Oncoimmunology. 2017 Feb 22;6(10):e1290036. doi: 10.1080/2162402X.2017.1290036. eCollection 2017.

Conventional cancer treatments remain insufficient to treat many therapy-resistant tumors.

Cite
Grippin AJ, Sayour EJ, Mitchell DA. Translational nanoparticle engineering for cancer vaccines. Oncoimmunology. 2017;6(10):e1290036doi: 10.1080/2162402X.2017.1290036.
Grippin, A. J., Sayour, E. J., & Mitchell, D. A. (2017). Translational nanoparticle engineering for cancer vaccines. Oncoimmunology, 6(10), e1290036. https://doi.org/10.1080/2162402X.2017.1290036
Grippin, Adam J, et al. "Translational nanoparticle engineering for cancer vaccines." Oncoimmunology vol. 6,10 (2017): e1290036. doi: https://doi.org/10.1080/2162402X.2017.1290036
Grippin AJ, Sayour EJ, Mitchell DA. Translational nanoparticle engineering for cancer vaccines. Oncoimmunology. 2017 Feb 22;6(10):e1290036. doi: 10.1080/2162402X.2017.1290036. eCollection 2017. PMID: 29123947; PMCID: PMC5665077.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 3819 entries